a public good project by the
Synthesis
Company
of California

© 2026

Yoshinori Ito | doi.page

0 works0 citations0 h-index

Yoshinori Ito

Showa University Hospital(JP)

Publications by Year

Research Areas

HER2/EGFR in Cancer Research, Esophageal Cancer Research and Treatment, Breast Cancer Treatment Studies, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology

Most-Cited Works

→ Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer(2011)2,803 cited
→ Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer(2017)2,484 cited
→ Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer(2019)1,908 cited
→ Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer(2019)1,885 cited
→ Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer(2011)712 cited
→ Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer(2015)599 cited

→ Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)

535 cited

→ Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1(2023)351 cited

→ Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)(2013)296 cited

→ Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy(2008)232 cited